Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 7,128,301 |
|
|||||
| News | - | ||||||
| Day High | 127.59 | Low High |
|||||
| Day Low | 125.35 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Merck and Co Inc | MRK | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.06 | 0.05% | 126.94 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 126.815 | 125.35 | 127.59 | 127.00 | 126.88 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 86,157 | 7,128,301 | $ 126.43 | $ 901,246,350 | - | 99.14 - 133.10 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:55:59 | formt | 153 | $ 126.94 | USD |
Merck (MRK) Options Flow Summary
Merck and Co Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 321.65B | 2.53B | - | 60.12B | 365M | 0.14 | 881.33 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Merck News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRK Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 126.23 | 128.10 | 124.50 | 126.10 | 7,408,892 | 0.71 | 0.56% |
| 1 Month | 132.87 | 133.10 | 124.50 | 127.97 | 7,188,501 | -5.93 | -4.46% |
| 3 Months | 122.53 | 133.10 | 119.41 | 125.49 | 8,354,433 | 4.41 | 3.60% |
| 6 Months | 103.20 | 133.10 | 99.80 | 116.19 | 8,352,888 | 23.74 | 23.00% |
| 1 Year | 115.85 | 133.10 | 99.14 | 113.01 | 7,691,379 | 11.09 | 9.57% |
| 3 Years | 78.00 | 133.10 | 70.89 | 93.33 | 9,978,757 | 48.94 | 62.74% |
| 5 Years | 74.73 | 133.10 | 65.25 | 88.24 | 9,979,193 | 52.21 | 69.86% |
Merck Description
| Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States. |
